Medical-Grade Ink Formulation & Supply

The contract entails the supply of a specialized non-toxic ink formulated with gentian violet, specifically designed for medical skin marking applications in surgical and clinical environments. The formulation must meet stringent safety and regulatory standards to ensure biocompatibility, sterility, and consistency in labeling patient skin prior to procedures, with no risk of adverse reactions or contamination. The product must be reliably produced and delivered to support the operational needs of medical personnel in high-stakes healthcare settings, adhering to quality control protocols consistent with FDA and Department of Defense guidelines. This subcontract is issued under the NAICS code 325520 for pharmaceutical and medicinal chemical manufacturing and is managed by the Department of Defense through its MEDICAL SUPPLY CHAIN MD SURG FSF office. Performance is required at the designated location in Groton, Connecticut, with a 06340-4905 ZIP code. Bidders must submit proposals by the deadline of July 27, 2026, following the solicitation posted on July 19, 2026. The procurement is part of a broader effort to secure consistent, compliant, and high-integrity medical supplies for military and veteran healthcare facilities, emphasizing safety, precision, and regulatory adherence above all other criteria.